Beirne Wealth Consulting Services, LLC Sarepta Therapeutics, Inc. Transaction History

Beirne Wealth Consulting Services, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 14, 2020	SELL	$76.53 - $135.58 $315,915 - $559,674	-4,128 Closed	0 $0
Q3 2019 Nov 07, 2019	SELL	$72.81 - $156.91 $16,527 - $35,618	-227 Reduced 5.21%	4,128 $311,000
Q2 2019 Jul 25, 2019	BUY	$112.21 - $151.95 $3,366 - $4,558	30 Added 0.69%	4,355 $662,000
Q1 2019 May 14, 2019	BUY	$106.67 - $151.68 $162,671 - $231,312	1,525 Added 54.46%	4,325 $515,000
Q4 2018 Feb 14, 2019	BUY	$97.32 - $148.76 $272,496 - $416,528	2,800 New	2,800 $306,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Beirne Wealth Consulting Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Beirne Wealth Consulting Services, LLC with notifications on news.